Dulan Lokuwithana is an Editor for Breaking News at NewsBreak. He specializes in areas such as medicine and healthcare, pharmaceuticals, finance, and legal affairs, with a focus on topics including drugs and medication, health news, and pharmaceutical regulation. Dulan's work has been featured in NewsBreak and Seeking Alpha.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Dulan Lokuwithana's articles predominantly focus on the healthcare and pharmaceutical industry, with an emphasis on investment analysis and press releases. To effectively pitch to Dulan, provide insights into the financial implications of developments within biotechnology, drug development, or pharmaceutical companies. This could include potential market impacts of new product launches, M&A activities, regulatory approvals or clinical trial results.
Given the high percentage of coverage attributes related to investment analysis and private sector announcements in his work, Dulan may be interested in pitches from professionals who can offer financial perspectives on company developments or those who have access to exclusive data supporting market trends within the healthcare and pharmaceutical sectors.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Sundry Photography/iStock Editorial via Getty Images Medtronic ( MDT ) traded higher in the premarket on Wednesday despite providing a
CatLane Shares of Axsome Therapeutics ( AXSM ) gained in the premarket on Wednesday after the company announced that it settled all patent
jetcityimage/iStock Editorial via Getty Images Boston, Massachusetts-based biotech Ascidian Therapeutics on Wednesday announced a research
CytomX Therapeutics ( CTMX ) traded higher in the morning hours on Wednesday after the cancer drug developer announced an expanded collaboration and licensing agreement with Regeneron Pharmaceuticals ( REGN ) valued up to $4B.
By: Dulan Lokuwithana
Medline ( MDLN ) shares slipped for the fourth consecutive session on Wednesday after the FDA issued a warning letter regarding several manufacturing lapses at a company's production facility in Illinois.
Medline (MDLN) stock drops as the FDA issues a warning letter detailing manufacturing issues at an Illinois plant. Read more here.
By: Dulan Lokuwithana
alexsl Rezolute ( RZLT ) traded higher for the third straight session on Wednesday after Citizens JMP Securities upgraded the stock, highlighting
AndreyPopov Inotiv ( NOTV ), a contract research organization focused on preclinical studies, has filed for bankruptcy in a U.S. bankruptcy court in Texas, the company announced on Wednesday.
By: Dulan Lokuwithana
Md Saiful Islam Khan/iStock via Getty Images TG Therapeutics ( TGTX ) added ~10% on Wednesday after data from an early-stage trial evaluating
JHVEPhoto Eli Lilly ( LLY ) CEO Dave Ricks told German business daily Handelsblatt that his company will halve its initially
